Early Experience Using New Integrated Table Motion for the da Vinci Xi in Gynecologic Surgery: Feasibility, Safety, Efficacy

Abstract

Objective: The aim of the present study was to examine feasibility, safety, and efficacy, in the first postmarket case series in gynecologic surgery, using an integrated table motion (ITM) device, which is a new surgical device including a unique operating table that connects wirelessly with the da Vinci® Xi surgical platform. This new feature is expected to advance robotic surgery and the field of minimally invasive gynecologic surgery. Materials and Methods: This was a prospective postmarket study, performed with ITM in 11 women who underwent gynecologic surgery. Primary endpoints were ITM feasibility, safety, and efficacy. Results: During the 11 gynecologic surgeries, there were 35 instances of table moves. The ITM length was <1 minute per movement in 25 of 35 moves (71%). During total robotic hysterectomy (TRH), the mean number of ITM movements was 3.1, resulting in 28 instances of table movements. During pelvic organ prolapse (POP) surgery, the mean number of ITM moves was 3.5, resulting in 7 instances of table moves. The mean duration of each table motion was 30 seconds during TRH, compared with 94 seconds during POP surgery. Of 35 ITM moves, 32 were performed to achieve internal exposure in the pelvis. The endoscope as well as the instruments remained inserted during 88% of table movements. No adverse events and no ITM safety-related remarks were noted in the medical records. Conclusions: Preliminary analysis of the early experience with using an ITM device as a new operating table, which communicates with da Vinci Xi platform, indicated the feasibility, safety, and efficacy of the ITM for different gynecologic surgeries. The small number of subjects in the first worldwide series of gynecologic surgeries as well the diversity of surgical procedures are not yet enough to provide definitive scientific evidence about the use of this device. However, the present study on humans concerning the use of ITM, highlighted the development of this new tool for robotic surgery performed for both benign and malignant gynecologic diseases. (J GYNECOL SURG 34:144)